Peptide record

TPDB05367

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05367
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0 ToxinPred 3.0
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GIWDTIKSMGKVFAGKILQNL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C107H175N27O28S1
RCEHPY
GIK
2319.79
10.32
3
1
10
+2
0.12
0.286
111.43
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5500
2.37
4
Residue Composition
number
1
A
0
R
1
N
1
D
0
C
0
E
1
Q
3
G
0
H
3
I
2
L
3
K
1
M
1
F
0
P
1
S
1
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 1 D: 1 C: 0 E: 0 Q: 1 G: 3 H: 0 I: 3 L: 2 K: 3 M: 1 F: 1 P: 0 S: 1 T: 1 W: 1 Y: 0 V: 1
Chemical Descriptors
21 reviewed residue count
C107H175N27O28S1 sequence-only estimate (linear, free termini)
2319.79 sequence-only estimate (linear, free termini)
10.32 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
0.12 sequence-only estimate (linear, free termini)
0.286 sequence-only estimate (linear, free termini)
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
13-25 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immun
Evidence 2 Activity

Activity

MIC
Antibacterial
25 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immunodeficiency Virus Type 1 HIV-1
Evidence 3 Activity

Activity

MIC
Antibacterial
25 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immunodeficiency Virus Type 1 HIV-1 (EC50 1.65 uM).
Evidence 4 Activity

Activity

MIC
Antifungal
13-25 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immun
Evidence 5 Activity

Activity

MIC
Antifungal
25 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immunodeficiency Virus Type 1 HIV-1
Evidence 6 Activity

Activity

MIC
Antifungal
25 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immunodeficiency Virus Type 1 HIV-1 (EC50 1.65 uM).
Evidence 7 Activity

Activity

MIC
Antiparasitic
13-25 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immun
Evidence 8 Activity

Activity

MIC
Antiparasitic
25 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immunodeficiency Virus Type 1 HIV-1
Evidence 9 Activity

Activity

MIC
Antiparasitic
25 µM

Target

Candida albicans

Source & Reference

dbAMP 3.0 DRAMP

Other

Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immunodeficiency Virus Type 1 HIV-1 (EC50 1.65 uM).
Evidence 10 Activity

Activity

MIC
Antiviral
13-25 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immun
Evidence 11 Activity

Activity

MIC
Antiviral
25 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immunodeficiency Virus Type 1 HIV-1
Evidence 12 Activity

Activity

MIC
Antiviral
25 µM

Target

Candida albicans

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Active against E. coli (MIC 13-25 uM), S. aureus or MRSA (MIC 25 uM), and C. albicans (MIC 25 uM). Virus: inhibited Human Immunodeficiency Virus Type 1 HIV-1 (EC50 1.65 uM).
Evidence 13 Activity

Activity

50% Hemolysis
Toxicity
90 µM
Hemolytic Cytotoxic
50% Hemolysis | 90 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial properties of brevinin-2-related peptide and its analogs: Efficacy against multidrug-resistant Acinetobacter baumannii | Chem Biol Drug Des | 2009
Evidence 14 Activity

Activity

50% Cell death
Toxicity
7.42 µM
Cytotoxic
50% Cell death | 7.42 | µM | target cell: CEM-SS cells

Target

CEM-SS cells

Source & Reference

NA
DBAASP
Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database | Antimicrob Agents Chemother | 2010
Evidence 15 Activity

Activity

HC50
Toxicity
70 µM
Hemolytic
Hemolytic_activity: [Ref.15556063]HC50=70 µM against human erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct 139(1-3):31-38.